Abstract
Molecular and cellular mechanisms of MDMA-induced toxicity have been extensively studied in a number of experimental models. Nevertheless, only few studies investigated the involvement of HSPs (“molecular chaperones”) in MDMA organs toxicity. In the present minireview we highlight this subject analysing the results of these studies conducted especially on brain tissue. Despite of it seems obvious that HSPs overexpression is a protective reaction against MDMA treatment, the molecular mechanisms for exerting their action are far to be undiscovered. At the same time, we need of comprehensive studies concerning the whole range of Hsps/chaperones expressions in all organs after acute and chronic administration of MDMA.
Keywords: 3,4-Methylenedioxy-N-methylamphetamine, brain toxicity, Hsp27, Hsp32, Hsp60, Hsp70
Current Pharmaceutical Biotechnology
Title: MDMA Administration and Heat Shock Proteins Response: Foreseeing a Molecular Link
Volume: 11 Issue: 5
Author(s): C. Pomara, S. D'Errico, L. Zummo, F. Cappello and G. Li Volti
Affiliation:
Keywords: 3,4-Methylenedioxy-N-methylamphetamine, brain toxicity, Hsp27, Hsp32, Hsp60, Hsp70
Abstract: Molecular and cellular mechanisms of MDMA-induced toxicity have been extensively studied in a number of experimental models. Nevertheless, only few studies investigated the involvement of HSPs (“molecular chaperones”) in MDMA organs toxicity. In the present minireview we highlight this subject analysing the results of these studies conducted especially on brain tissue. Despite of it seems obvious that HSPs overexpression is a protective reaction against MDMA treatment, the molecular mechanisms for exerting their action are far to be undiscovered. At the same time, we need of comprehensive studies concerning the whole range of Hsps/chaperones expressions in all organs after acute and chronic administration of MDMA.
Export Options
About this article
Cite this article as:
Pomara C., D'Errico S., Zummo L., Cappello F. and Li Volti G., MDMA Administration and Heat Shock Proteins Response: Foreseeing a Molecular Link, Current Pharmaceutical Biotechnology 2010; 11 (5) . https://dx.doi.org/10.2174/138920110791591445
DOI https://dx.doi.org/10.2174/138920110791591445 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on
the Latest Insights
Current Pharmaceutical Design Immunotherapy for Food Allergies in Children
Current Pharmaceutical Design Neurological Aspects of Medical Use of Cannabidiol
CNS & Neurological Disorders - Drug Targets Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery Patent Perspective for Potential Antioxidant Compounds-Rutin and Quercetin
Recent Patents on Nanomedicine Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry Perioperative Management of Obese Parturients
Current Women`s Health Reviews Therapeutic Drugs that Slow the Heart Rate of Early Rat Embryos. Is there a Risk for the Human?
Current Pharmaceutical Design Uteroplacental Circulation and Fetal Vascular Function and Development
Current Vascular Pharmacology Resistant Hypertension in the Elderly-Second Line Treatments: Aldosterone Antagonists, Central Alpha-Agonist Agents, Alpha-Adrenergic Receptor Blockers, Direct Vasodilators, and Exogenous Nitric Oxide Donors
Cardiovascular & Hematological Agents in Medicinal Chemistry Supramolecular Chiro-Biomedical Aspect of β-Blockers in Drug Development
Current Drug Targets Nitric Oxide Related Therapeutic Phenomenon: A Challenging Task
Current Pharmaceutical Design Citric Acid: A Green Bioorganic Catalyst for One-Pot Three-Component Synthesis of 2,3-dihydroquinazoline-4 (1H)-ones
Current Organocatalysis Emergence in Pyrazolines: Synthetic and Biological Perspective
The Natural Products Journal Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications
Current Vascular Pharmacology Hantaviruses: Molecular Biology, Evolution and Pathogenesis
Current Molecular Medicine Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts
Current Drug Safety Nitroxides as Cancer Imaging Agents
Anti-Cancer Agents in Medicinal Chemistry Coagulation and Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Coenzyme Q10 Reduction with Statins: Another Pleiotropic Effect
Current Drug Therapy